Tim Bourne
Oxford Science Park
Oxford, ENG, United Kingdom
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Corrigendum: An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis.
Journal: Frontiers in pharmacology
Published: August 12, 2024
Differential roles of CTP synthetases CTPS1 and CTPS2 in cell proliferation.
Journal: Life science alliance
Published: March 29, 2023
An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis.
Journal: Frontiers in pharmacology
Published: September 06, 2022
Transitioning EPMA applications in a large multisite teaching hospital.
Journal: BMJ open quality
Published: November 17, 2021
Codeveloping an effective EMPA to maturity in an acute NHS Trust: an implementer report.
Journal: BMJ health & care informatics
Published: August 31, 2021
MTHFD2 is a metabolic checkpoint controlling effector and regulatory T cell fate and function.
Journal: Immunity
Published: January 14, 2021
Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer.
Journal: Nature communications
Published: April 10, 2019
Efficacy of an Inhaled IL-13 Antibody Fragment in a Model of Chronic Asthma.
Journal: American journal of respiratory and critical care medicine
Published: June 09, 2018
Last Updated: 09/26/2026